An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of coronary arteries in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/15167972

Download in:

View as

General Info

PMID
15167972